Table 3.
Number of APs | GC3 (n = 13) | 1.0 (n = 10) | 1.1 (n = 10) | 1.2 (n = 9) | R (n = 9) | GEM (n = 9) |
---|---|---|---|---|---|---|
1 | 1.5 ± 0.8 | 1.4 ± 0.2 | 1.2 ± 0.4 | 1.1 ± 0.2 | 1.4 ± 0.9 | 0.9 ± 0.1** |
2 | 2.5 ± 1.6 | 2.4 ± 1.6 | 1.7 ± 0.5 | 1.4 ± 0.4* | 1.6 ± 0.9* | 1.0 ± 0.2*** |
5 | 7.2 ± 6.0 | 4.8 ± 3.2 | 4.1 ± 1.8 | 2.8 ± 1.2* | 2.4 ± 1.1** | 1.4 ± 0.3*** |
10 | 15 ± 12 | 8.3 ± 5.5 | 9.0 ± 4.9 | 5.8 ± 2.9* | 3.2 ± 1.2*** | 2.1 ± 0.8*** |
20 | 27 ± 22 | 15 ± 12 | 17 ± 9.2 | 10 ± 6.5* | 4.8 ± 2.1*** | 3.4 ± 1.0*** |
40 | 157 ± 39 | 103 ± 70 | 59 ± 12* | 73 ± 39 | 11 ± 3.1*** | 11 ± 3.2*** |
Action potentials (APs) were evoked at 20 Hz except for 40 APs evoked at 83 Hz. The numbers of recorded cells in the table apply to 1–20 APs; for 40 APs, n = 8 for GCaMP3 and R-GECO1, n = 7 for G-GECO1.0, and n = 9 for G-GECO1.1, G-GECO1.2 and GEM-GECO1. Significant difference in Dunn's post-hoc test comparing GCaMP3-expressing cells and GECO-expressing cells:
p < 0.05,
p < 0.01,
p < 0.001.